About NSTA - National Spasmodic Torticollis Association

Jill Ostrem, M.D.

10 Oct
Dr. Jill Ostrem

2012 Symposium Guest Speakers Jill Ostrem, M.D. Assistant Professor of Neurology in the UCSF School of Medicine Dr. Jill Ostrem specializes in the medical and surgical treatments of movement disorders, such as Parkinson’s disease, essential tremor and dystonia. She is particularly interested in treatments such as deep brain stimulation and gene therapy as well as […]

Brenda Wieber, RN, BSN, CPC

10 Oct

2012 Symposium Guest Speakers Brenda Wieber, RN, BSN, CPC Regional Reimbursement Manager for Merz Pharmaceuticals Brenda Wieber, RN, BSN, CPC, is a Regional Reimbursement Manager for Merz Pharmaceuticals.  She earned her BS degree in Nursing at the University of Minnesota.  With over 16 years of experience in the healthcare industry, Ms Wieber was a critical […]

Jay A. Van Gerpen, M.D.

09 Oct
Dr. JayVanGerpen

2012 Symposium Guest Speakers Jay A. Van Gerpen, M.D. Assistant Professor of Neurology at the Mayo Clinic Florida Dr. Van Gerpen is an Assistant Professor of Neurology at the Mayo Clinic Florida in Jacksonville. Dr. Van Gerpen graduated from the Vanderbilt University School of Medicine in Nashville Tennessee. He completed neurology residency at the University […]

Latest News

03 Oct

Dissertation on “Cervical Dystonia and the Black Community.” February 15, 2012 My Life with Cervical Dystonia! My name is Karen Chandler and I have cervical dystonia. I was born in Panama (Afro-Hispanic and I do not speak lick of Spanish, lol) and raised sin California, Michigan, and Florida. I was diagnosed with CD while I […]

News / Pharmaceuticals

03 Oct

Merz Pharmaceuticals Receives J-Code For Xeomin (incobotulinumtoxinA) January 10, 2012 Permanent Product-Specific Code Will Help Simplify Billing And Reimbursement GREENSBORO, N.C., January 4, 2012 /PRNewswire/ — Merz Pharmaceuticals, LLC, today announced that the Centers for Medicare and Medicaid Services (CMS) has assigned a product-specific Healthcare Common Procedure Coding System (HCPCS) billing code, J0588 “INJECTION, INCOBOTULINUMTOXIN […]

Special Events

02 Oct

2011 NSTA Symposium Information Las Vegas, Nevada – October 22nd and 23rd December 5, 2011 The 2011 NSTA symposium in Las Vegas, Nevada has passed and I am happy to report it was a huge success! We had over 130 people in attendance and the room was packed! We had so many people registering at […]

News & Events

01 Oct

Programs Feature Simple Enrollment and Meaningful Financial Assistance March 8, 2011 Allergan, Inc. is seeking patients who are or will be receiving onabotulinumtoxinA injections for the treatment of cervical dystonia for potential observational study participation. Eligible patients may receive a patient stipend for their participation. The CD-PROBE Study is a Multi-center, Prospective, Naturalistic, Observational Registry of Cervical […]

Latest News

01 Oct

Merz Pharmaceuticals Joins Patient Advocates To Raise Awareness Of Cervical Dystonia and Blepharospasm “Make Your Mark” Campaign Debuts Today Visit www.MakeYourMarkCampaign.com to Make Your Mark Greensboro, N.C., April 14 /PRNewswire/ — Merz Pharmaceuticals, LLC, maker of XEOMIN® (incobotulinumtoxinA), a botulinum toxin type A free from accessory proteins, today announced the launch of the “Make Your Mark” campaign. […]

“Ipsen Observational Registry Study”

01 Oct

March 9, 2011 Ipsen, manufacturer of Dysport for Injection (also known in the US as abobotulinumtoxinA neurotoxin), is contacting physicians to conduct an observational registry stud. The goal of the registry, ANCHOR-CD, is to collect and evaluate typical treatment response information from cervical dystonia patients currently being treated with market-available Dysport.  The registry will recruit up to 400 […]

News | Merz Pharmaceuticals….

29 Sep

Merz Pharmaceuticals Introduces Comprehensive Programs To Provide Patients With Financial Assistance For Xeomin® (incobotulinumtoxinA) Programs Feature Simple Enrollment And Meaningful Financial Assistance Greensboro, N.C., March 8, 2011/PRNewswire/ – Merz Pharmaceuticals today announced the launch of two programs to provide financial assistance to patients for their treatment with Xeomin (incobotulinumtoxinA). XEOMIN is a botulinum toxin type […]

Albuquerque, New Mexico

25 Sep

New Mexico Support Group Meeting NM Dystonia Support Group Meeting – Sat., Sept. 17 – 1-3PM El Camino Medical Center, 8100 Constitution Place, Albuquerque Speaker: Amanda Reyes, Ocusoft Pharmaceutical RSVP – AJ @ 505-298-6129 or deguio@comcast.net This support group a collaboration with the Dystonia Medical Research Foundation, a non-profit organization dedicated to advancing research for more treatments […]